Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04480086 |
| Title | Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stony Brook University Hospital /ID# 222653 | Stony Brook | New York | 11794-8183 | United States | Details | |
| UC Health - Cincinnati /ID# 224079 | Cincinnati | Ohio | 45267-2800 | United States | Details | |
| Thompson Cancer Survival Ctr /ID# 225802 | Knoxville | Tennessee | 37916 | United States | Details | |
| University of Texas MD Anderson Cancer Center /ID# 221652 | Houston | Texas | 77030 | United States | Details | |
| Inje University Busan Paik Hospital /ID# 224043 | Busan | 47392 | Korea, Republic of | Details | ||
| Wits Clinical Research , Wits Health Consortium (PTY) Ltd /ID# 222669 | Johannesburg | Gauteng | 2193 | South Africa | Details | |
| Alberts Cellular Therapy /ID# 222667 | Pretoria | Gauteng | 0044 | South Africa | Details |